JAMA

In this column for the JAMA Health Forum, Larry Levitt explores what President-elect Biden might do to advance his health care vision both through legislation and through executive orders and waivers and demonstrations.

In this post, Ashley Kirzinger and Mollyann Brodie examine how the COVID-19 pandemic and other crises shook up the mix of issues voters care about without changing the 2020 presidential race’s core dynamic as a referendum on President Trump’s first term in office.

Based on an analysis of electronic health records, Black, Hispanic, and Asian patients had significantly higher rates of hospitalization and death compared to their White counterparts.

In this September 2020 post for The JAMA Health Forum, Larry Levitt highlights differences in the records and policy plans of President Donald Trump and former Vice President Joe Biden on key health care issues.

In this May 2020 post for The JAMA Health Forum, Larry Levitt explores how the massive and rapid job losses of the past few months will test the ACA’s coverage safety net – and how different policies could strengthen or weaken it.

In this February 2020 post for The JAMA Health Forum, Mollyann Brodie and Ashley Kirzinger examine the role health care has played in the primary election to date, what the polling data says about the issue, including Medicare-for-all and a public option, and what to expect from the issue during the rest of the 2020 election campaign.

This infographic examines public opinion on surprise medical billing in the United States as part of the Visualizing Health Policy infographic series, produced in partnership with the Journal of the American Medical Association (JAMA).

This Visualizing Health Policy infographic looks at the experience of unexpected or “surprise” medical bills in the United States. Out-of-network charges typically expose individuals to higher cost-sharing when they use services, and may lead to balance billing – in which providers bill patients directly, and often unexpectedly, at a higher…

In this post for The JAMA Forum, Larry Levitt examines both the Democratic candidates’ proposals and the Trump administration’s record on lowering drug prices, which remains a top issue for the public with bi-partisan support.